New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
People over 40 with type 1 diabetes and COVID-19 are more likely to be hospitalized

People over 40 with type 1 diabetes and COVID-19 are more likely to be hospitalized

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainAdults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new
Diabetes & Endocrinology January 29,2024
People over 40 with type 1 diabetes and COVID-19 are more likely to be hospitalized

People over 40 with type 1 diabetes and COVID-19 are more likely to be hospitalized

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainAdults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new
Diabetes & Endocrinology January 29,2024
Could the nerve cells that scratch be the solution for itch?

Could the nerve cells that scratch be the solution for itch?

byUniversity of California, San FranciscoCredit: CC0 Public DomainIt can be a relief to scratch the occasional itch, but when itch gets out of control, it can become a serious health problem. Ho
Dermatology January 29,2024
Could the nerve cells that scratch be the solution for itch?

Could the nerve cells that scratch be the solution for itch?

byUniversity of California, San FranciscoCredit: CC0 Public DomainIt can be a relief to scratch the occasional itch, but when itch gets out of control, it can become a serious health problem. Ho
Dermatology January 29,2024
Alzheimer's disease: Problems with the brain's energy supply could be a cause

Alzheimer's disease: Problems with the brain's energy supply could be a cause

by Afshan Malik,The ConversationCredit: AI-generated imageScientists have been working to understand the root causes of dementia and Alzheimer's disease for decades now. But one of the reaso
Diabetes & Endocrinology January 29,2024
Alzheimer's disease: Problems with the brain's energy supply could be a cause

Alzheimer's disease: Problems with the brain's energy supply could be a cause

by Afshan Malik,The ConversationCredit: AI-generated imageScientists have been working to understand the root causes of dementia and Alzheimer's disease for decades now. But one of the reaso
Diabetes & Endocrinology January 29,2024
Study: Race, ethnicity may play a role in cause of liver cancer

Study: Race, ethnicity may play a role in cause of liver cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainA new analysis of liver cancer has identified racial and ethnic differences and emerging trends for thi
Oncology January 29,2024
Study: Race, ethnicity may play a role in cause of liver cancer

Study: Race, ethnicity may play a role in cause of liver cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainA new analysis of liver cancer has identified racial and ethnic differences and emerging trends for thi
Oncology January 29,2024
Researchers test 'holy grail' tech that could end chemo for some cancer patients

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th
Oncology January 29,2024
Researchers test 'holy grail' tech that could end chemo for some cancer patients

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th
Oncology January 29,2024
Simple test could lead to more personalized treatment of rare ovarian cancer

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl
Oncology January 29,2024
Simple test could lead to more personalized treatment of rare ovarian cancer

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl
Oncology January 29,2024
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Oncology January 29,2024
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Oncology January 29,2024
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com